Luan Danny, DeWolf Susan, Fei Teng, Raj Sandeep, Shah Gunjan L, Lareau Caleb A, Alhomoud Mohammad, Salles Gilles, Rivas-Delgado Alfredo, Rejeski Kai, Park Jae H, Luttwak Efrat, Luna de Abia Alejandro, Corona Magdalena, Ntrivalas Evangelos, Cassanello Giulio, Gomez-Llobell Marina, Parascondola Allison, Scordo Michael, Hsu Katharine C, Palomba M Lia, Perales Miguel-Angel, Shouval Roni
Department of Medicine, Weill Cornell Medicine, New York, New York.
Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Blood Cancer Discov. 2025 Mar 4;6(2):119-130. doi: 10.1158/2643-3230.BCD-24-0163.
This study reveals differences in IR patterns after CAR-T therapy in patients with large B-cell lymphoma, with early NK cell recovery emerging as a key predictor of survival. These findings provide potential future avenues of research for improving patient outcomes and tailoring post-therapy management strategies to mitigate relapse risk.
本研究揭示了大B细胞淋巴瘤患者接受CAR-T治疗后免疫重建模式的差异，早期自然杀伤细胞恢复是生存的关键预测指标。这些发现为未来改善患者预后以及制定治疗后管理策略以降低复发风险提供了潜在的研究途径。
